Tobacco-Related Carcinoma
Conditions
Brief summary
This trial studies the main and interactive effects of episodic future thinking and future thinking priming tasks on helping participants to quit smoking. Episodic future thinking and future thinking priming tasks may decrease delay discounting rates and reduce relapse to smoking and help participants quit smoking.
Detailed description
PRIMARY OBJECTIVE: I. To quantify the main and interactive effects of the episodic future thinking (EFT) and future thinking priming (FTP) tasks on delay discounting rate, latency to relapse, and multiple abstinence and self-regulation measures among smokers (n=76) who call a busy Quitline to quit smoking. OUTLINE: Participants are randomized to 1 of 4 arms. ARM I: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks. ARM II: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or control future thinking priming task once per week for 12 weeks, alternating every week between tasks. ARM III: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks. ARM IV: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or control future thinking priming tasks once per week for 12 weeks, alternating every week between tasks.
Interventions
Receive nicotine patches, gum, or lozenges
OTHERTelephone-Based Intervention
Receive coaching call
BEHAVIORALBehavioral Intervention
Complete active episodic thinking task
OTHERInformational Intervention
Provided with Forever Free relapse prevention booklet
Sponsors
Roswell Park Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Smoke \>= 8 cigarettes daily * Planning to quit in the next 14 days * No regular use of other tobacco products * Access to the internet * In possession of a smartphone with text messaging capabilities * In possession of an email address accessible at least every other day
Exclusion criteria
* Unable or unwilling to provide consent * Unable to provide data to the research team after the quit date * Current use of bupropion or varenicline * Drinking \>= 20 alcoholic drinks per week * Use of drugs of abuse in the past 30 days * Living in the same household as a participant already enrolled in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Delay discounting rate | Baseline, and 4 and 12 weeks after quit date | Assessed with the 5-Trial Adjusting Delay Discounting. |
| Latency to relapse | Baseline, assessed up to 12 weeks | Will be assessed with the Timeline Follow-Back procedure administered by telephone. Analyzed using generalized mixed models. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of days abstinent | Up to 12 weeks | Will be evaluated by cox proportional-hazards survival model analyses. |
| 7-day point prevalence abstinence rates | At 4 and 12 weeks after quit date | Will be evaluated by cox proportional-hazards survival model analyses. |
| Ability to regulate behavior to achieve goals | Up to 12 weeks | Assessed with the Short Self-Regulation Questionnaire. |
| Behavioral inhibition and behavioral activation | Up to 12 weeks | Assessed with the Behavioral Avoidance/Inhibition scales. |
| Self-control | Up to 12 weeks | Assessed with the Brief Self-Control Survey. |
| Attentional, motor, and non-planning impulsiveness | Up to 12 weeks | Assessed with the Barratt Impulsiveness Scale. |
| Latency to first relapse | up to 12 weeks | Defined as the number of days until first relapse (any smoking for seven consecutive days). Will be assessed with the Timeline Follow-Back procedure administered by telephone. Analyzed using generalized mixed models. |
Countries
United States
Outcome results
None listed